Pulmonary embolism (PE) poses a significant threat to COVID-19 patients, escalating morbidity and mortality. Predictive tools such as PESI, Wells, and Revised Geneva scores offer vital insights into the 30-day mortality risk, aiding in clinical decision-making.
Dogan et al. (Sun,) studied this question.